Literature DB >> 32477586

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Kimberly Legault1, Mark Blostein2, Marc Carrier3, Susan Kahn2, Sam Schulman1, Sudeep Shivakumar4, Cynthia Wu5, Mark A Crowther1.   

Abstract

[This corrects the article DOI: 10.1186/s40814-020-00594-1.].
© The Author(s) 2020.

Entities:  

Year:  2020        PMID: 32477586      PMCID: PMC7236369          DOI: 10.1186/s40814-020-00614-0

Source DB:  PubMed          Journal:  Pilot Feasibility Stud        ISSN: 2055-5784


  1 in total

1.  A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Authors:  Kimberly Legault; Mark Blostein; Marc Carrier; Susan Khan; Sam Schulman; Sudeep Shivakumar; Cynthia Wu; Mark A Crowther
Journal:  Pilot Feasibility Stud       Date:  2020-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.